Work

P1.12B.02 Mechanisms of Resistance to First-Line vs Later-Line Alectinib in ALK Fusion-Positive Non-Small Cell Lung Cancer

Year: 2024

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.09.361

Authors: S. Waliany, A. Do, A. Liu, J. Peterson, A. Hata, I. Dagogo-Jack, J. Gainor, J.J. Lin

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,000

OpenAlex ID: W4403410097

FWCI: 0.507

Cites:

Cited by: 2

Related to: 10